Eurofarma Laboratórios S.A. Stock

Stocks

EUFA3

BREUFAACNOR4

Market Closed - Sao Paulo Other stock markets			5-day change	1st Jan Change
- ^BRL	-.--%		-.--%	-

05-15	Eurofarma Laboratórios S.A. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
03-26	Eurofarma Laboratórios S.A. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI

Latest news : Eurofarma Laboratórios S.A.

05-15	Eurofarma Laboratórios S.A. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
03-26	Eurofarma Laboratórios S.A. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI
01-23	Bavarian Nordic A/S Signs Distribution Agreement with Eurofarma to Expand Access to Chikungunya Vaccine in Brazil	CI
12-10	Psivant Therapeutics, Inc. announced that it has received $47.5 million in funding from YK Bioventures, Samsara BioCapital LLC, Roivant Sciences Ltd., LSV Capital Management, LLC, Eurofarma Laboratórios S.A. and other investors	CI
11-14	Eurofarma Laboratórios S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
25-10-21	Mentis Care, Inc Appoints Hassan Kotob as Chief Executive Officer	CI
25-10-21	SK Biopharmaceuticals Co., Ltd. Launches Joint Venture with Eurofarma for Ai-Based Epilepsy Management Platform	CI
25-08-21	Eurofarma Laboratórios S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
25-05-15	Eurofarma Laboratórios S.A. Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
25-03-26	Eurofarma Laboratórios S.A. Reports Earnings Results for the Full Year Ended December 31, 2024	CI
25-03-16	Eurofarma Laboratórios S.A. acquired 60% stake in Klibra Agenciamento de Marcas e Negócios for approximately BRL 160 million.	CI
24-11-14	Eurofarma Laboratórios S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	CI
24-08-13	Eurofarma Laboratórios S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	CI

More news

Managers and Directors: Eurofarma Laboratórios S.A.

Manager	Title	Age	Since
Marco Billi CEO	Chief Executive Officer	-	2021-11-22
Alexandre Mendes Palhares IRC	Investor Relations Contact	-	2021-11-22

Director	Title	Age	Since
Maurízio Billi CHM	Chairman	-	2021-11-22
Cristina Presz Palmaka de Luca BRD	Director/Board Member	57	2021-11-22
Juliana Rozenbaum Munemori BRD	Director/Board Member	50	2018-12-31

More insiders

Latest insider transactions

Date	Insider	Type	Quantity	% Market Cap.
25-01-09	Controlling Shareholder Brazilian	Buy	1,644,236	0.1665%
24-12-03	Controlling Shareholder Brazilian	Sell	15,405,639	1.5600%
24-12-03	Controlling Shareholder Brazilian	Buy	15,405,639	1.5600%

Transaction History

Financials

	2024	2025
Net sales	10.97B 2.15B 1.88B 1.73B 1.6B 3.04B 205B 3.09B 20.7B 8.13B 101B 8.06B 7.89B 347B	12.48B 2.44B 2.14B 1.97B 1.82B 3.45B 233B 3.51B 23.54B 9.25B 115B 9.17B 8.97B 394B
Net income	117M 22.96M 20.08M 18.52M 17.11M 32.46M 2.19B 33M 221M 86.9M 1.08B 86.19M 84.32M 3.71B	571M 112M 97.84M 90.24M 83.35M 158M 10.67B 161M 1.08B 423M 5.26B 420M 411M 18.07B
Net Debt	-	-

* Estimated data More financial data

Company Profile

Employees

13,000

Sector

More about the company

Income Statement and Estimates

More financial data